Gene therapy: An out-of-body experience
On April 1, 2016, the European Medicines Agency (EMA) approved the first ex-vivo (outside the body) gene therapy in the Western Hemisphere. Diseased stem cells
Read More
On April 1, 2016, the European Medicines Agency (EMA) approved the first ex-vivo (outside the body) gene therapy in the Western Hemisphere. Diseased stem cells
Read MoreIs it possible that Zika has already entered Aedes aegypti mosquito populations within the continental United States and that people in the at-risk areas of
Read MoreWithin the Center of Medical Ethics and Health Policy at Baylor College of Medicine, the Narrative Medicine program has begun taking roots. Founded by Dr.
Read MoreAs a recent hire of Baylor College of Medicine Center for Medical Ethics and Health Policy, I was allowed a unique opportunity to watch high-level
Read MoreHolland Kaplan, a third-year medical student in Baylor College of Medicine Center for Medical Ethics and Health Policy’s Ethics Track, will have the opportunity to
Read MoreGiven the opportunity, would you take a test to determine your chances of developing cancer or a disease like Alzheimer’s disease? Amy McGuire, Leon Jaworski
Read MoreAs techniques such as next generation sequencing, which determines the precise order of the nucleotides that make up DNA, are used in patient diagnosis and
Read MoreThis feature is part of an ongoing series that focuses on VIICTR.org, highlighting clinical and translational research at Baylor College of Medicine. Is it ethical to inform
Read MoreIn the face of the Ebola outbreak plaguing West Africa, an experimental treatment is being administered to patients. However, medical ethicists are questioning whether untested
Read MoreA key research arm of our National School of Tropical Medicine at Baylor College of Medicine is the Sabin Vaccine Institute and Texas Children’s Hospital
Read More